NCT01074749

Optimal Sensing in Atrial Tachyarrhythmia's Study

OSAT: Optimal Sensing in Atrial Tachyarrhythmia's Study

• Status: Terminated
• Phase: N/A
• Study type: Interventional
• Enrollment: 111 (actual)
• Sponsor: Abbott Medical Devices · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The aim of the study is the comparison of two different leads in their capabilities to detect episodes and duration of paroxysmal atrial fibrillation (AF) and atrial tachyarrhythmia (AT), and the rejection of far field sensing of the far field R-wave (FFRW).

Detailed description

The aim of the study is the comparison of two different leads in their capabilities to detect episodes and duration of paroxysmal AF and AT and the rejection of far field sensing of the far field R-wave (FFRW). The study aims to evaluate the accuracy of the detection of atrial tachyarrhythmias (ATAs). An improved detection can potentially increase the accuracy of clinical treatment decisions, based on device derived data.

Conditions

• Sick Sinus Syndrome
• Paroxysmal Atrial Fibrillation

Interventions

Type	Name	Description
DEVICE	Accent Pacemaker	Implantation of pacemaker

Timeline

• Start date: 2010-07-01
• Primary completion: 2014-04-01
• Completion: 2014-07-01
• First posted: 2010-02-24
• Last updated: 2019-02-04

Locations

1 site across 1 country: Netherlands